87 related articles for article (PubMed ID: 34624841)
1. Absence of the RNF213 p.R4810K variant may indicate a severe form of pediatric moyamoya disease in Japanese patients.
Hara S; Mukawa M; Akagawa H; Thamamongood T; Inaji M; Tanaka Y; Maehara T; Kasuya H; Nariai T
J Neurosurg Pediatr; 2022 Jan; 29(1):48-56. PubMed ID: 34624841
[TBL] [Abstract][Full Text] [Related]
2. Moyamoya disease in Southeast Asians: genetic and autopsy data, new cases, systematic review, and meta-analysis of all patients from the literature.
Strunk D; Bauer P; Keyvani K; Diehl RR; Veltkamp R; Berlit P; Meuth SG; Timmermann L; Schwitalla JC; Kraemer M
J Neurol; 2024 Jun; 271(6):3328-3339. PubMed ID: 38478032
[TBL] [Abstract][Full Text] [Related]
3. Synergistic Interaction of Thyroid Autoantibodies and Ring Finger Protein 213 Variant in Moyamoya Disease.
Thamamongood T; Hara S; Akagawa H; Inaji M; Tanaka Y; Nariai T; Maehara T
Neurol Med Chir (Tokyo); 2024 Jan; 64(1):43-49. PubMed ID: 38057092
[TBL] [Abstract][Full Text] [Related]
4. Association of RNF213 polymorphism and cortical hyperintensity sign on fluid-attenuated inversion recovery images after revascularization surgery for moyamoya disease: possible involvement of intrinsic vascular vulnerability.
Uchino H; Ito M; Tokairin K; Tatezawa R; Sugiyama T; Kazumata K; Fujimura M
Neurosurg Rev; 2023 May; 46(1):119. PubMed ID: 37166684
[TBL] [Abstract][Full Text] [Related]
5. A Noonan-like pediatric patient with a de novo CBL pathogenic variant and an RNF213 polymorphism p.R4810K presenting with cardiopulmonary arrest due to left main coronary artery ostial atresia.
Chida-Nagai A; Tonoki H; Makita N; Ishiyama H; Ihara M; Maruo Y; Tsujioka T; Sasaki D; Izumi G; Yamazawa H; Kato N; Ito M; Fujimura M; Sasaki O; Takeda A
Am J Med Genet A; 2023 Dec; 191(12):2837-2842. PubMed ID: 37554039
[TBL] [Abstract][Full Text] [Related]
6. Detailed phenotype of
Zhou H; Jing J; Pu Y; Li W; Meng X; Wang A; Zuo Y; Xu Z; Xu Q; Suo Y; Li H; Wang Y
Stroke Vasc Neurol; 2023 Dec; 8(6):503-510. PubMed ID: 37137523
[TBL] [Abstract][Full Text] [Related]
7. Posterior cerebral artery involvement in unilateral moyamoya disease is exclusively ipsilateral and influenced by RNF213 mutation gene dose: The SUPRA Japan study: PCA involvement in unilateral moyamoya.
Mineharu Y; Takagi Y; Koizumi A; Morimoto T; Funaki T; Hishikawa T; Araki Y; Hasegawa H; Takahashi JC; Kuroda S; Houkin K; Miyamoto S;
J Stroke Cerebrovasc Dis; 2024 Feb; 33(2):107513. PubMed ID: 38141320
[TBL] [Abstract][Full Text] [Related]
8. RNF213 vasculopathy manifested in various forms within a family: A case report.
Lim SS; Park S; Oh BH; Jung K; Bae JW; Bae DH
Medicine (Baltimore); 2023 Dec; 102(50):e36627. PubMed ID: 38115307
[TBL] [Abstract][Full Text] [Related]
9. RNF213-Related Vasculopathy: Various Systemic Vascular Diseases Involving RNF213 Gene Mutations: Review.
Murai Y; Matano F; Kubota A; Nounaka Y; Ishisaka E; Shirokane K; Koketsu K; Nakae R; Tamaki T
J Nippon Med Sch; 2024; 91(2):140-145. PubMed ID: 38777780
[TBL] [Abstract][Full Text] [Related]
10. Different phenotypes of moyamoya disease in a Chinese familial case involving heterozygous c.14429G>a variant in RNF213.
Li F; Huang YY; Zhang S; Wang W
Br J Neurosurg; 2023 Dec; 37(6):1882-1885. PubMed ID: 35642380
[TBL] [Abstract][Full Text] [Related]
11. Association of thyroid peroxidase antibody with the RNF213 p.R4810K variant in ischemic stroke/transient ischemic attack.
Yoshimoto T; Ishiyama H; Hattori Y; Nishimura K; Okada Y; Watanabe H; Ohyagi Y; Akaiwa Y; Miyamoto T; Kawamoto M; Ichijo M; Inoue H; Matsukawa N; Mizuno T; Matsuyama H; Tomimoto H; Kawakami D; Toyoda K; Koga M; Ihara M
Atherosclerosis; 2023 Oct; 382():117281. PubMed ID: 37722316
[TBL] [Abstract][Full Text] [Related]
12. Moyamoya disease factor RNF213 is a giant E3 ligase with a dynein-like core and a distinct ubiquitin-transfer mechanism.
Ahel J; Lehner A; Vogel A; Schleiffer A; Meinhart A; Haselbach D; Clausen T
Elife; 2020 Jun; 9():. PubMed ID: 32573437
[TBL] [Abstract][Full Text] [Related]
13. De novo variants in RNF213 are associated with a clinical spectrum ranging from Leigh syndrome to early-onset stroke.
Brunet T; Zott B; Lieftüchter V; Lenz D; Schmidt A; Peters P; Kopajtich R; Zaddach M; Zimmermann H; Hüning I; Ballhausen D; Staufner C; Bianzano A; Hughes J; Taylor RW; McFarland R; Devlin A; Mihaljević M; Barišić N; Rohlfs M; Wilfling S; Sondheimer N; Hewson S; Marinakis NM; Kosma K; Traeger-Synodinos J; Elbracht M; Begemann M; Trepels-Kottek S; Hasan D; Scala M; Capra V; Zara F; van der Ven AT; Driemeyer J; Apitz C; Krämer J; Strong A; Hakonarson H; Watson D; Mayr JA; Prokisch H; Meitinger T; Borggraefe I; Spiegler J; Baric I; Paolini M; Gerstl L; Wagner M
Genet Med; 2024 Feb; 26(2):101013. PubMed ID: 37924258
[TBL] [Abstract][Full Text] [Related]
14. Regression of periventricular anastomosis after indirect revascularization in pediatric patients with moyamoya disease.
Zheng EY; Hara S; Inaji M; Tanaka Y; Nariai T; Maehara T
J Neurosurg Pediatr; 2023 Dec; 32(6):719-728. PubMed ID: 37773770
[TBL] [Abstract][Full Text] [Related]
15. Impact of RNF213 c.14576G>A Variant on the Development of Direct and Indirect Revascularization in Pediatric Moyamoya Disease.
Kawabori M; Ito M; Kazumata K; Tokairin K; Hatanaka KC; Ishikawa S; Houkin K; Fujimura M
Cerebrovasc Dis; 2023; 52(2):171-176. PubMed ID: 36063804
[TBL] [Abstract][Full Text] [Related]
16. RNF213 loss-of-function promotes pathological angiogenesis in moyamoya disease via the Hippo pathway.
Ye F; Niu X; Liang F; Dai Y; Liang J; Li J; Wu X; Zheng H; Qi T; Sheng W
Brain; 2023 Nov; 146(11):4674-4689. PubMed ID: 37399508
[TBL] [Abstract][Full Text] [Related]
17. Neuregulin 1 as a potential biomarker for disease progression in moyamoya disease: A case-control study in Chinese population.
Chen J; Zheng H; Wu X; Niu X; Dai Y; Zhou Z; Ye F
J Stroke Cerebrovasc Dis; 2024 Mar; 33(3):107581. PubMed ID: 38224792
[TBL] [Abstract][Full Text] [Related]
18. Risk Factors for Massive Cerebral Infarction in Pediatric Patients With Moyamoya Disease.
Hao F; Gao G; Guo Q; Liu S; Wang M; Chang Z; Wang H; Lu M; Liu S; Zou Z; Zhang Q; Wang X; Fu H; Li J; Han C; Duan L
Pediatr Neurol; 2024 Apr; 153():159-165. PubMed ID: 38394830
[TBL] [Abstract][Full Text] [Related]
19. Aplastic or twig-like middle cerebral artery and cardiogenic cerebral embolism mimicking moyamoya disease with RNF213 polymorphism: A case report.
Inoue H; Oomura M; Nishikawa Y; Mase M; Matsukawa N
Interv Neuroradiol; 2022 Dec; 28(6):634-638. PubMed ID: 34913393
[TBL] [Abstract][Full Text] [Related]
20. Arg4810Lys mutation in RNF213 among Eastern Indian non-MMD ischemic stroke patients: a genotype-phenotype correlation.
Sadhukhan D; Mitra P; Mishra S; Roy A; Podder G; Ray BK; Biswas A; Hui SP; Banerjee TK; Biswas A
Neurol Sci; 2024 Jan; 45(1):315-319. PubMed ID: 37698787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
